[{"address1": "7750 El Camino Real", "address2": "Suite 2A", "city": "Carlsbad", "state": "CA", "zip": "92009", "country": "United States", "phone": "858 704 4900", "website": "https://www.palisadebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. J. D. Finley", "age": 66, "title": "CEO, CFO & Director", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 813000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mitchell Lawrence Jones M.D., Ph.D.", "age": 47, "title": "COO & Chief Medical Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 581000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joerg  Heyer Ph.D.", "title": "Head of Translational Science & Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryker  Willie", "title": "Senior VP of Finance & Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.7003, "open": 0.7003, "dayLow": 0.69, "dayHigh": 0.72, "regularMarketPreviousClose": 0.7003, "regularMarketOpen": 0.7003, "regularMarketDayLow": 0.69, "regularMarketDayHigh": 0.72, "payoutRatio": 0.0, "beta": 1.378, "forwardPE": -0.078936405, "volume": 46393, "regularMarketVolume": 46393, "averageVolume": 319772, "averageVolume10days": 54480, "averageDailyVolume10Day": 54480, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 3309128, "fiftyTwoWeekLow": 0.6, "fiftyTwoWeekHigh": 9.09, "fiftyDayAverage": 0.8428, "twoHundredDayAverage": 2.4524, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -6496854, "profitMargins": 0.0, "floatShares": 4089276, "sharesOutstanding": 4396650, "sharesShort": 176377, "sharesShortPriorMonth": 148042, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.038399998, "heldPercentInsiders": 0.00506, "heldPercentInstitutions": 0.04531, "shortRatio": 0.27, "shortPercentOfFloat": 0.0403, "impliedSharesOutstanding": 4596650, "bookValue": 2.705, "priceToBook": 0.2661368, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -14438000, "trailingEps": -10.19, "forwardEps": -9.12, "lastSplitFactor": "1:15", "lastSplitDate": 1712534400, "enterpriseToEbitda": 0.437, "52WeekChange": -0.8539554, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 0.7199, "targetHighPrice": 16.0, "targetLowPrice": 2.0, "targetMeanPrice": 10.66667, "targetMedianPrice": 14.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 9833000, "totalCashPerShare": 2.236, "ebitda": -14856000, "totalDebt": 169000, "quickRatio": 3.046, "currentRatio": 3.243, "debtToEquity": 2.256, "returnOnAssets": -0.74498004, "returnOnEquity": -1.5355499, "freeCashflow": -7644375, "operatingCashflow": -12193000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PALI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Palisade Bio, Inc.", "longName": "Palisade Bio, Inc.", "corporateActions": [], "regularMarketTime": 1744920000, "exchange": "NCM", "messageBoardId": "finmb_244367385", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.79881, "regularMarketPrice": 0.7199, "marketState": "CLOSED", "fiftyDayAverageChange": -0.12290001, "fiftyDayAverageChangePercent": -0.14582345, "twoHundredDayAverageChange": -1.7325, "twoHundredDayAverageChangePercent": -0.7064508, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Seneca Biopharma, Inc.", "nameChangeDate": "2025-04-18", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1175261400000, "regularMarketChange": 0.0196, "regularMarketDayRange": "0.69 - 0.72", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 319772, "fiftyTwoWeekLowChange": 0.11989999, "fiftyTwoWeekLowChangePercent": 0.1998333, "fiftyTwoWeekRange": "0.6 - 9.09", "fiftyTwoWeekHighChange": -8.3701, "fiftyTwoWeekHighChangePercent": -0.92080307, "fiftyTwoWeekChangePercent": -85.39554, "dividendDate": 1563408000, "earningsTimestamp": 1742846400, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -10.19, "epsForward": -9.12, "epsCurrentYear": -2.005, "priceEpsCurrentYear": -0.35905236, "displayName": "Palisade Bio", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]